The homegrown drug maker Dr Reddy's Laboratories announced that it has acquired a portfolio of branded and generic injectable products from...

The portfolio includes the Biorphen (phenylephrine hydrocholoride) injection and Rezipres (ephedrine hydrochloride) injection NDAs (new dru...

A number of funds also took positions in pharmaceuticals stock Perrigo, including Kyle Bass of Hayman Capital.